Dual focus contact lens can reduce myopia progression

The results of the CooperVision-funded study of its one-day MiSight lenses were presented by senior manager of clinical research Dr Paul Chamberlain during the recent British Contact Lens Association Clinical Conference in Liverpool, England.{{quote-A:R-W:450-I:2-Q:“Early intervention by parents, in partnership with eyecare professionals, is essential to the near- and long-term health and well-being of their children,”-WHO:Dr Arthur Back, CooperVision chief technology officer}}They showed that the dual-focus contact lenses were effective in slowing the progression of myopia by 59% based on a mean cycloplegic spherical equivalent measurent and 52% by mean axial elongation of the eye.The results were determined by comparing the MiSight users with children belonging to a control group who uses only single vision contact lenses over the same period.“Early intervention by parents, in partnership with eyecare professionals, is essential to the near- and long-term health and well-being of their children,” CooperVision chief technology officer Dr Arthur Back said.“The CooperVision MiSight dual-focus 1-day lens used in this study provides a new, effective and repeatable approach.”Back also said the trials, which involved 144 myopic children aged 8–12-years-old from Singapore, Canada, England and Portugal, had garnered positive feedback from parents of the test participants, with nine out of 10 rating their children as “extrely happy” and mostly able manage their own lens wear routines.CooperVision is currently working with the Food and Drug Administration regarding the results of the trials, but no timeline has been suggested for the approval or release of the product to the market.